It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2014.
2014 | Kolkata, West Bengal, India | ActiveRebound Pharma Private Limited, a active private limited company, was established on 31 July 2014 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52100WB2014PTC202785. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.25 M.
It upholds a compliant status. Its leadership includes Gaurav Agarwal (Director), Sourav Agarwal (Additional Director). Past directors included Sushil Kumar Agarwal, Rakesh Kumar Lunia. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 111, Ashoka Appartment, Shop No B Dr. Meghnand Saha Sarani ( Southurn Aven, Ue), Kolkata, West Bengal, 700029.
U52100WB2014PTC202785
202785
31 July 2014
₹2.50 M
₹2.25 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Rebound Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Agarwal | Director | 19 Oct 2016 | Current |
| Sourav Agarwal | Additional Director | 10 Jan 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jan 2015 | Past |
| Pramod Abcsdd | Director | 15 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rebound Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.72% increase. The company also saw a substantial fall in profitability, with a 253.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Rebound Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2017 | Others | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rebound Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rebound Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebound Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rebound Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Rebound Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Kolkata. was documented.
A charge with Others amounted to Rs. 2.00 M with Charge ID 100106542 was registered on 22 Mar 2017. was recorded as a recent event.
Gaurav Agarwal was appointed as a Director was appointed as a Director on 19 Oct 2016 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
Progress on Sourav Agarwal was appointed as a Additional Director was appointed as a Additional Director on 10 Jan 2015 & has been associated with this company since 10 years 10 months . was documented.
Progress on Rebound Pharma Private Limited was registered on 31 Jul 2014 with Roc Kolkata & aged 11 years 3 months as per MCA records. was documented.
The CIN of Rebound Pharma Private Limited is U52100WB2014PTC202785.
Rebound Pharma Private Limited is headquartered at 111, Ashoka Appartment, Shop No B Dr. Meghnand Saha Sarani ( Southurn Aven, Ue), Kolkata, West Bengal, 700029.
Rebound Pharma Private Limited was incorporated on 31 July 2014.
The current directors of Rebound Pharma Private Limited are
The primary industry of Rebound Pharma Private Limited is Trade.
Rebound Pharma Private Limited is unlisted.
The authorized capital of Rebound Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.25 M.
The compliance status of Rebound Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX